120
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study

, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 3229-3237 | Published online: 25 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?. Expert Opinion on Pharmacotherapy 23:8, pages 917-927.
Read now

Articles from other publishers (2)

Subash Heraganahally, Timothy P Howarth, Siji Issac, Angus Lloyd, Shiidheshwar J Ravichandran, Asanga Abeyaratne & Bhavini Patel. (2023) Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study. BMJ Open Respiratory Research 10:1, pages e001508.
Crossref
Ralph Brattsand & Olof Selroos. (2022) May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?. Pulmonary Pharmacology & Therapeutics 77, pages 102167.
Crossref